Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Updated results from a phase 2 trial.
Year: 2023
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Chung-Han Lee, Kelly N. Fitzgerald, Martin H Voss, Maria Isabel Carlo, Andrea Knezevic, Laura Peralta, Ying-Bei Chen, Mark Zucker, Robert A Lefkowitz, Eduard Reznik, Neil J. Shah, Colette Ngozi Owens, Deaglan Joseph McHugh, David H Aggen, Andrew Leonard Laccetti, Ritesh R Kotecha, Darren R. Feldman, Robert J. Motzer
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4379281972